Jeffrey S Mathiesen - Net Worth and Insider Trading
Jeffrey S Mathiesen Net Worth
The estimated net worth of Jeffrey S Mathiesen is at least $50 dollars as of 2024-11-07. Jeffrey S Mathiesen is the CFO and Treasurer of Helius Medical Technologies Inc and owns about 79 shares of Helius Medical Technologies Inc (HSDT) stock worth over $47. Jeffrey S Mathiesen is also the CFO of NeuroBo Pharmaceuticals Inc and owns about 1 shares of NeuroBo Pharmaceuticals Inc (NRBO) stock worth over $3. Details can be seen in Jeffrey S Mathiesen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey S Mathiesen has not made any transactions after 2021-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey S Mathiesen
Jeffrey S Mathiesen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S Mathiesen owns 7 companies in total, including Panbela Therapeutics Inc (PBLA) , NeuroOne Medical Technologies Corp (NMTC) , and Helius Medical Technologies Inc (HSDT) among others .
Click here to see the complete history of Jeffrey S Mathiesen’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S Mathiesen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBLA | Panbela Therapeutics Inc | 2015-09-24 | director |
| NMTC | NeuroOne Medical Technologies Corp | 2017-08-04 | director |
| HSDT | Helius Medical Technologies Inc | 2022-09-13 | director & CFO and Treasurer |
 | | 2016-08-10 | Chief Financial Officer |
| | 2013-09-08 | Chief Financial Officer |
| | 2005-10-06 | Vice President and CFO |
| | 2022-03-31 | director |
Jeffrey S Mathiesen Latest Holdings Summary
Jeffrey S Mathiesen currently owns a total of 2 stocks. Among these stocks, Jeffrey S Mathiesen owns 79 shares of Helius Medical Technologies Inc (HSDT) as of December 17, 2021, with a value of $47 and a weighting of 94.52%. Jeffrey S Mathiesen also owns 1 shares of NeuroBo Pharmaceuticals Inc (NRBO) as of August 10, 2016, with a value of $3 and a weighting of 5.48%.
Latest Holdings of Jeffrey S Mathiesen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HSDT | Helius Medical Technologies Inc | 2021-12-17 | 79 | 0.60 | 47 |
| NRBO | NeuroBo Pharmaceuticals Inc | 2016-08-10 | 1 | 2.74 | 3 |
Holding Weightings of Jeffrey S Mathiesen
Jeffrey S Mathiesen Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S Mathiesen has made a total of 1 transactions in Helius Medical Technologies Inc (HSDT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Helius Medical Technologies Inc is the acquisition of 60 shares on December 17, 2021, which cost Jeffrey S Mathiesen around $15,930.
According to the SEC Form 4 filings, Jeffrey S Mathiesen has made a total of 0 transactions in NeuroBo Pharmaceuticals Inc (NRBO) over the past 5 years. The most-recent trade in NeuroBo Pharmaceuticals Inc is the acquisition of 1 shares on August 10, 2016, which cost Jeffrey S Mathiesen around $40,000.
Insider Trading History of Jeffrey S Mathiesen
- 1
Jeffrey S Mathiesen Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S Mathiesen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S Mathiesen is -19.2%. GuruFocus also compares Jeffrey S Mathiesen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S Mathiesen within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S Mathiesen's insider trading performs compared to the benchmark.
Performance of Jeffrey S Mathiesen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.89 | | | | | |
| Relative Return to S&P 500(%) | 16.53 | | | | | |
Jeffrey S Mathiesen Ownership Network
Ownership Network List of Jeffrey S Mathiesen
Ownership Network Relation of Jeffrey S Mathiesen
Jeffrey S Mathiesen Owned Company Details
What does Panbela Therapeutics Inc do?
Who are the key executives at Panbela Therapeutics Inc?
Jeffrey S Mathiesen is the director of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , V.P. of Finance & CFO Susan Horvath , and 10 percent owner Ryan Randall Gilbertson .
Panbela Therapeutics Inc (PBLA) Insider Trades Summary
Over the past 18 months, Jeffrey S Mathiesen made no insider transaction in Panbela Therapeutics Inc (PBLA). Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc ,
In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,644 shares.
Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Panbela Therapeutics Inc Insider Transactions
Jeffrey S Mathiesen Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S Mathiesen. You might contact Jeffrey S Mathiesen via mailing address: 43334 Seven Mile Rd., Suite 1000, Northville Mi 48167.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
